We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$54B
AUM Growth
-$3.2B
Cap. Flow
-$865M
Cap. Flow %
-1.6%
Top 10 Hldgs %
28.71%
Holding
986
New
116
Increased
314
Reduced
359
Closed
149

Top Buys

Rank Stock Value
1
HUBB icon
Hubbell
HUBB
+$244M
2
NSC icon
Norfolk Southern
NSC
+$149M
3
INSM icon
Insmed
INSM
+$138M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131M
5
DHR icon
Danaher
DHR
+$119M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$340M
2
BMY icon
Bristol-Myers Squibb
BMY
+$339M
3
UNP icon
Union Pacific
UNP
+$191M
4
MCD icon
McDonald's
MCD
+$190M
5
HES
Hess
HES
+$168M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Healthcare 14.99%
3 Financials 12.56%
4 Consumer Discretionary 9.54%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTTR
976
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
-4,128,554
Closed -$19.6M
HCP
977
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-1,679,356
Closed -$57.5M
NARI
978
DELISTED
Inari Medical, Inc. Common Stock
NARI
-296,543
Closed -$15.1M
ZUO
979
DELISTED
Zuora, Inc.
ZUO
-1,222,187
Closed -$12.1M
ROIC
980
DELISTED
Retail Opportunity Investments Corp.
ROIC
-100,000
Closed -$1.74M
SUM
981
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-1,405,712
Closed -$71.1M
RVNC
982
DELISTED
Revance Therapeutics, Inc.
RVNC
-1,653,689
Closed -$5.03M
CDMO
983
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-357,041
Closed -$4.41M
CITEW
984
DELISTED
Cartica Acquisition Corp Warrant
CITEW
-200,000
Closed -$200
GEAR
985
DELISTED
Revelyst, Inc.
GEAR
-1,265,474
Closed -$24.3M

Similar funds

Adage Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adage Capital Partners held 986 positions worth $54B, down 5.6% from $57.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners's Q1 2025 filing shows 116 new, 314 increased, 359 reduced and 149 closed positions. Its largest new stake was Diamondback Energy: 485,503 shares worth $77.6M. The largest sale was Royalty Pharma, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2025 buy was Diamondback Energy: 485,503 shares worth $77.6M.
  • Adage Capital Partners added most to Hubbell in Q1 2025, an estimated $244M increase.
  • Adage Capital Partners's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $340M.
  • Adage Capital Partners fully exited Geron in Q1 2025, selling an estimated $77.2M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $54B portfolio in Q1 2025.
  • Adage Capital Partners opened 116 new positions and closed 149 in Q1 2025.
  • Adage Capital Partners's portfolio value fell 5.6% quarter-over-quarter to $54B.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.